The global market for Enzalutamide Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Enzalutamide drugs are medications that contain enzalutamide, an androgen receptor inhibitor that works by blocking the effects of androgens (male hormones like testosterone) on cancer cells.

North American market for Enzalutamide Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Enzalutamide Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Enzalutamide Drugs include Astellas Pharma, Pfizer, Intas Pharmaceuticals, Beacon pharma, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, Sun Pharma, Zydus, Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enzalutamide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzalutamide Drugs.

The Enzalutamide Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enzalutamide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enzalutamide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Enzalutamide Drugs Market Report

Report Metric	Details
Report Name	Enzalutamide Drugs Market
Segment by Type	Tablets Capsules
Segment by Application	Hospital and Clinic Retail Pharmacies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Astellas Pharma, Pfizer, Intas Pharmaceuticals, Beacon pharma, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, Sun Pharma, Zydus, Abbott Laboratories, BDR Pharma, Qilu Pharmaceutical, Kelun Pharmaceutical, Yichang Humanwell Pharmaceutical, Jiangsu Hansoh Pharmaceutical, PuraCap Pharmaceuticals, Shenyang Hongqi Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enzalutamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enzalutamide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Enzalutamide Drugs Market report?

Ans: The main players in the Enzalutamide Drugs Market are Astellas Pharma, Pfizer, Intas Pharmaceuticals, Beacon pharma, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, Sun Pharma, Zydus, Abbott Laboratories, BDR Pharma, Qilu Pharmaceutical, Kelun Pharmaceutical, Yichang Humanwell Pharmaceutical, Jiangsu Hansoh Pharmaceutical, PuraCap Pharmaceuticals, Shenyang Hongqi Pharmaceutical

What are the Application segmentation covered in the Enzalutamide Drugs Market report?

Ans: The Applications covered in the Enzalutamide Drugs Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Enzalutamide Drugs Market report?

Ans: The Types covered in the Enzalutamide Drugs Market report are Tablets, Capsules

1 Enzalutamide Drugs Market Overview

1.1 Product Definition

1.2 Enzalutamide Drugs by Type

1.2.1 Global Enzalutamide Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tablets

1.2.3 Capsules

1.3 Enzalutamide Drugs by Application

1.3.1 Global Enzalutamide Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital and Clinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Global Enzalutamide Drugs Market Size Estimates and Forecasts

1.4.1 Global Enzalutamide Drugs Revenue 2020-2031

1.4.2 Global Enzalutamide Drugs Sales 2020-2031

1.4.3 Global Enzalutamide Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Enzalutamide Drugs Market Competition by Manufacturers

2.1 Global Enzalutamide Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Enzalutamide Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Enzalutamide Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Enzalutamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Enzalutamide Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Enzalutamide Drugs, Product Type & Application

2.7 Global Key Manufacturers of Enzalutamide Drugs, Date of Enter into This Industry

2.8 Global Enzalutamide Drugs Market Competitive Situation and Trends

2.8.1 Global Enzalutamide Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Enzalutamide Drugs Players Market Share by Revenue

2.8.3 Global Enzalutamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Enzalutamide Drugs Market Scenario by Region

3.1 Global Enzalutamide Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Enzalutamide Drugs Sales by Region: 2020-2031

3.2.1 Global Enzalutamide Drugs Sales by Region: 2020-2025

3.2.2 Global Enzalutamide Drugs Sales by Region: 2026-2031

3.3 Global Enzalutamide Drugs Revenue by Region: 2020-2031

3.3.1 Global Enzalutamide Drugs Revenue by Region: 2020-2025

3.3.2 Global Enzalutamide Drugs Revenue by Region: 2026-2031

3.4 North America Enzalutamide Drugs Market Facts & Figures by Country

3.4.1 North America Enzalutamide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Enzalutamide Drugs Sales by Country (2020-2031)

3.4.3 North America Enzalutamide Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Enzalutamide Drugs Market Facts & Figures by Country

3.5.1 Europe Enzalutamide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Enzalutamide Drugs Sales by Country (2020-2031)

3.5.3 Europe Enzalutamide Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enzalutamide Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Enzalutamide Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Enzalutamide Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Enzalutamide Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Enzalutamide Drugs Market Facts & Figures by Country

3.7.1 Latin America Enzalutamide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Enzalutamide Drugs Sales by Country (2020-2031)

3.7.3 Latin America Enzalutamide Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Enzalutamide Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Enzalutamide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Enzalutamide Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Enzalutamide Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Enzalutamide Drugs Sales by Type (2020-2031)

4.1.1 Global Enzalutamide Drugs Sales by Type (2020-2025)

4.1.2 Global Enzalutamide Drugs Sales by Type (2026-2031)

4.1.3 Global Enzalutamide Drugs Sales Market Share by Type (2020-2031)

4.2 Global Enzalutamide Drugs Revenue by Type (2020-2031)

4.2.1 Global Enzalutamide Drugs Revenue by Type (2020-2025)

4.2.2 Global Enzalutamide Drugs Revenue by Type (2026-2031)

4.2.3 Global Enzalutamide Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Enzalutamide Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Enzalutamide Drugs Sales by Application (2020-2031)

5.1.1 Global Enzalutamide Drugs Sales by Application (2020-2025)

5.1.2 Global Enzalutamide Drugs Sales by Application (2026-2031)

5.1.3 Global Enzalutamide Drugs Sales Market Share by Application (2020-2031)

5.2 Global Enzalutamide Drugs Revenue by Application (2020-2031)

5.2.1 Global Enzalutamide Drugs Revenue by Application (2020-2025)

5.2.2 Global Enzalutamide Drugs Revenue by Application (2026-2031)

5.2.3 Global Enzalutamide Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Enzalutamide Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Astellas Pharma

6.1.1 Astellas Pharma Company Information

6.1.2 Astellas Pharma Description and Business Overview

6.1.3 Astellas Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Astellas Pharma Enzalutamide Drugs Product Portfolio

6.1.5 Astellas Pharma Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Enzalutamide Drugs Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Intas Pharmaceuticals

6.3.1 Intas Pharmaceuticals Company Information

6.3.2 Intas Pharmaceuticals Description and Business Overview

6.3.3 Intas Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Intas Pharmaceuticals Enzalutamide Drugs Product Portfolio

6.3.5 Intas Pharmaceuticals Recent Developments/Updates

6.4 Beacon pharma

6.4.1 Beacon pharma Company Information

6.4.2 Beacon pharma Description and Business Overview

6.4.3 Beacon pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Beacon pharma Enzalutamide Drugs Product Portfolio

6.4.5 Beacon pharma Recent Developments/Updates

6.5 Aprazer Healthcare Pharma

6.5.1 Aprazer Healthcare Pharma Company Information

6.5.2 Aprazer Healthcare Pharma Description and Business Overview

6.5.3 Aprazer Healthcare Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolio

6.5.5 Aprazer Healthcare Pharma Recent Developments/Updates

6.6 Arechar Healthcare

6.6.1 Arechar Healthcare Company Information

6.6.2 Arechar Healthcare Description and Business Overview

6.6.3 Arechar Healthcare Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Arechar Healthcare Enzalutamide Drugs Product Portfolio

6.6.5 Arechar Healthcare Recent Developments/Updates

6.7 Glenmark Pharma

6.7.1 Glenmark Pharma Company Information

6.7.2 Glenmark Pharma Description and Business Overview

6.7.3 Glenmark Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Glenmark Pharma Enzalutamide Drugs Product Portfolio

6.7.5 Glenmark Pharma Recent Developments/Updates

6.8 Sun Pharma

6.8.1 Sun Pharma Company Information

6.8.2 Sun Pharma Description and Business Overview

6.8.3 Sun Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sun Pharma Enzalutamide Drugs Product Portfolio

6.8.5 Sun Pharma Recent Developments/Updates

6.9 Zydus

6.9.1 Zydus Company Information

6.9.2 Zydus Description and Business Overview

6.9.3 Zydus Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Zydus Enzalutamide Drugs Product Portfolio

6.9.5 Zydus Recent Developments/Updates

6.10 Abbott Laboratories

6.10.1 Abbott Laboratories Company Information

6.10.2 Abbott Laboratories Description and Business Overview

6.10.3 Abbott Laboratories Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Abbott Laboratories Enzalutamide Drugs Product Portfolio

6.10.5 Abbott Laboratories Recent Developments/Updates

6.11 BDR Pharma

6.11.1 BDR Pharma Company Information

6.11.2 BDR Pharma Description and Business Overview

6.11.3 BDR Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 BDR Pharma Enzalutamide Drugs Product Portfolio

6.11.5 BDR Pharma Recent Developments/Updates

6.12 Qilu Pharmaceutical

6.12.1 Qilu Pharmaceutical Company Information

6.12.2 Qilu Pharmaceutical Description and Business Overview

6.12.3 Qilu Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Qilu Pharmaceutical Enzalutamide Drugs Product Portfolio

6.12.5 Qilu Pharmaceutical Recent Developments/Updates

6.13 Kelun Pharmaceutical

6.13.1 Kelun Pharmaceutical Company Information

6.13.2 Kelun Pharmaceutical Description and Business Overview

6.13.3 Kelun Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Kelun Pharmaceutical Enzalutamide Drugs Product Portfolio

6.13.5 Kelun Pharmaceutical Recent Developments/Updates

6.14 Yichang Humanwell Pharmaceutical

6.14.1 Yichang Humanwell Pharmaceutical Company Information

6.14.2 Yichang Humanwell Pharmaceutical Description and Business Overview

6.14.3 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolio

6.14.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates

6.15 Jiangsu Hansoh Pharmaceutical

6.15.1 Jiangsu Hansoh Pharmaceutical Company Information

6.15.2 Jiangsu Hansoh Pharmaceutical Description and Business Overview

6.15.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolio

6.15.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates

6.16 PuraCap Pharmaceuticals

6.16.1 PuraCap Pharmaceuticals Company Information

6.16.2 PuraCap Pharmaceuticals Description and Business Overview

6.16.3 PuraCap Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.16.4 PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolio

6.16.5 PuraCap Pharmaceuticals Recent Developments/Updates

6.17 Shenyang Hongqi Pharmaceutical

6.17.1 Shenyang Hongqi Pharmaceutical Company Information

6.17.2 Shenyang Hongqi Pharmaceutical Description and Business Overview

6.17.3 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolio

6.17.5 Shenyang Hongqi Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Enzalutamide Drugs Industry Chain Analysis

7.2 Enzalutamide Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enzalutamide Drugs Production Mode & Process Analysis

7.4 Enzalutamide Drugs Sales and Marketing

7.4.1 Enzalutamide Drugs Sales Channels

7.4.2 Enzalutamide Drugs Distributors

7.5 Enzalutamide Drugs Customer Analysis

8 Enzalutamide Drugs Market Dynamics

8.1 Enzalutamide Drugs Industry Trends

8.2 Enzalutamide Drugs Market Drivers

8.3 Enzalutamide Drugs Market Challenges

8.4 Enzalutamide Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Intas Pharmaceuticals

Yichang Humanwell Pharmaceutical

Jiangsu Hansoh Pharmaceutical

Puracap Pharmaceuticals

Shenyang Hongqi Pharmaceutical

Aprazer Healthcare Pharma

Arechar Healthcare

Astellas Pharma

Pfizer Inc

List of Tables

Table 1. Global Enzalutamide Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Enzalutamide Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Enzalutamide Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Enzalutamide Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Enzalutamide Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Enzalutamide Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Enzalutamide Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Enzalutamide Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Enzalutamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Enzalutamide Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Enzalutamide Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Enzalutamide Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Enzalutamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Enzalutamide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Enzalutamide Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Enzalutamide Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Enzalutamide Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Enzalutamide Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Enzalutamide Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Enzalutamide Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Enzalutamide Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Enzalutamide Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Enzalutamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Enzalutamide Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Enzalutamide Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Enzalutamide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Enzalutamide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Enzalutamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Enzalutamide Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Enzalutamide Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Enzalutamide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Enzalutamide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Enzalutamide Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Enzalutamide Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Enzalutamide Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Enzalutamide Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Enzalutamide Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Enzalutamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Enzalutamide Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Enzalutamide Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Enzalutamide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Enzalutamide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Enzalutamide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Enzalutamide Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Enzalutamide Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Enzalutamide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Enzalutamide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Enzalutamide Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Enzalutamide Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Enzalutamide Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Enzalutamide Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Enzalutamide Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Enzalutamide Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Enzalutamide Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Enzalutamide Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Enzalutamide Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Enzalutamide Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Enzalutamide Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Enzalutamide Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Enzalutamide Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Enzalutamide Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Enzalutamide Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Enzalutamide Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Enzalutamide Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Enzalutamide Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Enzalutamide Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Enzalutamide Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Astellas Pharma Company Information

Table 71. Astellas Pharma Description and Business Overview

Table 72. Astellas Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Astellas Pharma Enzalutamide Drugs Product

Table 74. Astellas Pharma Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Enzalutamide Drugs Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Intas Pharmaceuticals Company Information

Table 81. Intas Pharmaceuticals Description and Business Overview

Table 82. Intas Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Intas Pharmaceuticals Enzalutamide Drugs Product

Table 84. Intas Pharmaceuticals Recent Developments/Updates

Table 85. Beacon pharma Company Information

Table 86. Beacon pharma Description and Business Overview

Table 87. Beacon pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Beacon pharma Enzalutamide Drugs Product

Table 89. Beacon pharma Recent Developments/Updates

Table 90. Aprazer Healthcare Pharma Company Information

Table 91. Aprazer Healthcare Pharma Description and Business Overview

Table 92. Aprazer Healthcare Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Aprazer Healthcare Pharma Enzalutamide Drugs Product

Table 94. Aprazer Healthcare Pharma Recent Developments/Updates

Table 95. Arechar Healthcare Company Information

Table 96. Arechar Healthcare Description and Business Overview

Table 97. Arechar Healthcare Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Arechar Healthcare Enzalutamide Drugs Product

Table 99. Arechar Healthcare Recent Developments/Updates

Table 100. Glenmark Pharma Company Information

Table 101. Glenmark Pharma Description and Business Overview

Table 102. Glenmark Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Glenmark Pharma Enzalutamide Drugs Product

Table 104. Glenmark Pharma Recent Developments/Updates

Table 105. Sun Pharma Company Information

Table 106. Sun Pharma Description and Business Overview

Table 107. Sun Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Sun Pharma Enzalutamide Drugs Product

Table 109. Sun Pharma Recent Developments/Updates

Table 110. Zydus Company Information

Table 111. Zydus Description and Business Overview

Table 112. Zydus Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Zydus Enzalutamide Drugs Product

Table 114. Zydus Recent Developments/Updates

Table 115. Abbott Laboratories Company Information

Table 116. Abbott Laboratories Description and Business Overview

Table 117. Abbott Laboratories Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Abbott Laboratories Enzalutamide Drugs Product

Table 119. Abbott Laboratories Recent Developments/Updates

Table 120. BDR Pharma Company Information

Table 121. BDR Pharma Description and Business Overview

Table 122. BDR Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. BDR Pharma Enzalutamide Drugs Product

Table 124. BDR Pharma Recent Developments/Updates

Table 125. Qilu Pharmaceutical Company Information

Table 126. Qilu Pharmaceutical Description and Business Overview

Table 127. Qilu Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Qilu Pharmaceutical Enzalutamide Drugs Product

Table 129. Qilu Pharmaceutical Recent Developments/Updates

Table 130. Kelun Pharmaceutical Company Information

Table 131. Kelun Pharmaceutical Description and Business Overview

Table 132. Kelun Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Kelun Pharmaceutical Enzalutamide Drugs Product

Table 134. Kelun Pharmaceutical Recent Developments/Updates

Table 135. Yichang Humanwell Pharmaceutical Company Information

Table 136. Yichang Humanwell Pharmaceutical Description and Business Overview

Table 137. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product

Table 139. Yichang Humanwell Pharmaceutical Recent Developments/Updates

Table 140. Jiangsu Hansoh Pharmaceutical Company Information

Table 141. Jiangsu Hansoh Pharmaceutical Description and Business Overview

Table 142. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product

Table 144. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates

Table 145. PuraCap Pharmaceuticals Company Information

Table 146. PuraCap Pharmaceuticals Description and Business Overview

Table 147. PuraCap Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. PuraCap Pharmaceuticals Enzalutamide Drugs Product

Table 149. PuraCap Pharmaceuticals Recent Developments/Updates

Table 150. Shenyang Hongqi Pharmaceutical Company Information

Table 151. Shenyang Hongqi Pharmaceutical Description and Business Overview

Table 152. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product

Table 154. Shenyang Hongqi Pharmaceutical Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Enzalutamide Drugs Distributors List

Table 158. Enzalutamide Drugs Customers List

Table 159. Enzalutamide Drugs Market Trends

Table 160. Enzalutamide Drugs Market Drivers

Table 161. Enzalutamide Drugs Market Challenges

Table 162. Enzalutamide Drugs Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Enzalutamide Drugs

Figure 2. Global Enzalutamide Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Enzalutamide Drugs Market Share by Type: 2024 & 2031

Figure 4. Tablets Product Picture

Figure 5. Capsules Product Picture

Figure 6. Global Enzalutamide Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Enzalutamide Drugs Market Share by Application: 2024 & 2031

Figure 8. Hospital and Clinic

Figure 9. Retail Pharmacies

Figure 10. Other

Figure 11. Global Enzalutamide Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Enzalutamide Drugs Market Size (2020-2031) & (US$ Million)

Figure 13. Global Enzalutamide Drugs Sales (2020-2031) & (K Units)

Figure 14. Global Enzalutamide Drugs Average Price (US$/Unit) & (2020-2031)

Figure 15. Enzalutamide Drugs Report Years Considered

Figure 16. Enzalutamide Drugs Sales Share by Manufacturers in 2024

Figure 17. Global Enzalutamide Drugs Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Enzalutamide Drugs Players: Market Share by Revenue in Enzalutamide Drugs in 2024

Figure 19. Enzalutamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Enzalutamide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Enzalutamide Drugs Sales Market Share by Country (2020-2031)

Figure 22. North America Enzalutamide Drugs Revenue Market Share by Country (2020-2031)

Figure 23. United States Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Enzalutamide Drugs Sales Market Share by Country (2020-2031)

Figure 26. Europe Enzalutamide Drugs Revenue Market Share by Country (2020-2031)

Figure 27. Germany Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Enzalutamide Drugs Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Enzalutamide Drugs Revenue Market Share by Region (2020-2031)

Figure 34. China Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Enzalutamide Drugs Sales Market Share by Country (2020-2031)

Figure 42. Latin America Enzalutamide Drugs Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Enzalutamide Drugs Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Enzalutamide Drugs Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Enzalutamide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Enzalutamide Drugs by Type (2020-2031)

Figure 53. Global Revenue Market Share of Enzalutamide Drugs by Type (2020-2031)

Figure 54. Global Enzalutamide Drugs Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Enzalutamide Drugs by Application (2020-2031)

Figure 56. Global Revenue Market Share of Enzalutamide Drugs by Application (2020-2031)

Figure 57. Global Enzalutamide Drugs Price (US$/Unit) by Application (2020-2031)

Figure 58. Enzalutamide Drugs Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions